These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31987863)

  • 21. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
    Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
    Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
    Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
    Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking.
    Tabbara RI; Li Z; Fletcher PJ; Lê AD
    Addict Biol; 2021 Sep; 26(5):e13040. PubMed ID: 33928736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
    Rady JJ; Fujimoto JM
    Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.
    Lemberg KK; Siiskonen AO; Kontinen VK; Yli-Kauhaluoma JT; Kalso EA
    Anesth Analg; 2008 Feb; 106(2):463-70, table of contents. PubMed ID: 18227301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.
    Kopruszinski CM; Swiokla J; Lee YS; Navratilova E; VanderVeen L; Yang M; Liu Y; Miyazaki T; Schmidt WK; Zalevsky J; Porreca F
    Cell Mol Neurobiol; 2021 Jul; 41(5):949-960. PubMed ID: 32107752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.
    Suzuki T; Nurrochmad A; Ozaki M; Khotib J; Nakamura A; Imai S; Shibasaki M; Yajima Y; Narita M
    Neuropharmacology; 2005 Dec; 49(8):1121-31. PubMed ID: 16095635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
    Kuo A; Wyse BD; Meutermans W; Smith MT
    Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
    Nakamura A; Fujita M; Ono H; Hongo Y; Kanbara T; Ogawa K; Morioka Y; Nishiyori A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kato A; Hasegawa M
    Br J Pharmacol; 2014 Jan; 171(1):253-64. PubMed ID: 24117458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists.
    Karim F; Roerig SC
    Pain; 2000 Aug; 87(2):181-191. PubMed ID: 10924811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S; Zhang Z; Patterson N; Gulati A
    Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D
    DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED
    Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
    Andurkar SV; Gendler L; Gulati A
    Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
    Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
    Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice.
    Sakakihara M; Imamachi N; Saito Y
    Reg Anesth Pain Med; 2016; 41(1):69-74. PubMed ID: 26587674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pimavanserin and lorcaserin on alcohol self-administration and reinstatement in male and female rats.
    Fletcher PJ; Li Z; Ji X; Higgins GA; Funk D; Lê AD
    Neuropharmacology; 2022 Sep; 215():109150. PubMed ID: 35644487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.